Clinical Trial Update: Intradiscal and Intra-articular Injection of Autologous Platelet-Rich-Plasma (PRP) in Patients With Lumbar Degenerative Disc Disease and Facet Joint Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating autologous platelet-rich plasma injections for lumbar degenerative disc disease and facet joint syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Facet Joint Syndrome

Drugs mentioned

• Autologous Platelet-Rich Plasma (PRP) (platelet-rich plasma)

Snippet

Sponsor: Stylianos Kapetanakis | Conditions: Degenerative Disc Disease, Facet Joint Syndrome | Phase 3 | Status: UNKNOWN